drugset / Trial / NCT02276001

Drug-Drug Interaction Study in Healthy Adult Volunteers

NCT02276001

Phase 1 Completed 20 enrolled Kowa Research Institute, Inc.
Non-randomizedSingle-groupOpen-label

Summary

The primary objective of this study is to assess the effects of cyclosporine on the pharmacokinetics of K-877 in healthy adult subjects.

Timeline

Start
2014-06
Primary completion
2014-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide
Subject K-877 Unknown

Indications

No indication recorded.